Pseudomembranous panenteritis and septicaemia in a patient with ulcerative colitis

Australian and New Zealand Journal of Surgery

Volumn 66, Issue 8, 1996, Pages 565-567

  Chen, F C S ^a,b   Woods, R ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Clostridium difficile; panenteritis; pseudomembranous colitis; ulcerative colitis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; MALE; POSTOPERATIVE COMPLICATION; PSEUDOMEMBRANOUS COLITIS; SEPTICEMIA; ULCERATIVE COLITIS;

EID: 0029780280     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1996.tb00815.x     Document Type: Article

References (27)

1. Schrock T. Pseudomembranous colitis. In: Way L (ed.). Current Surgical Diagnosis and Treatment. Connecticut: Lange Medical Publications, 1991; 674.
2. Shortland J, Spencer R, Williams J. Pseudomembranous colitis associated with changes in an ileal conduit. J. Clin. Pathol. 1983; 36: 1184-7.
3. Hugh T. Pseudomembranous colitis. Aust. N.Z. J. Surg. 1983; 62: 515-17.
4. Goligher J. Pseudomembranous colitis. In: Goligher J (ed.). Surgery of the Anus, Rectum and Colon. London: Balliere Tindall, 1984; 1024-7.
5. Rybolt A, Bennett R, Laughon B et al. Protein losing enteropathy associated with Clostridium difficile infection. Lancet 1989; 1: 1353.
6. Price A. Pseudomembranous colitis. In: Wright R (ed.). Recent Advances in Gastrointestinal Pathology. London: W.B. Saunders Co Ltd., 1980; 151-72.
7. Bartlett J, Chang T, Gurwith M et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 1987; 298: 531-4.
8. Bartlett J, Onderdonk A, Cisneros E et al. Clindamycin-associated colitis due to a toxin-producing species of clostridium in hamsters. J. Infect. Dis. 1977; 136: 701-5.
9. Bartlett J. Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhoea or colitis. Johns Hopkins Med. J. 1981; 149: 6-9.
10. Thompson G, Clark A, Hare K et al. Pseudomembranous colitis after treatment with metronidazole. Br. Med. J. 1981; 282: 804.
11. Fekety R. Antibiotic-associated pseudomembranous colitis. Clin. Microbiol. Newsl. October, 1978.
12. Pittman F. Antibiotic-associated colitis: An update. Adv. Drug Reaction Bull. 75, April 1979.
13. Pierce P, Wilson R, Silva J et al. Antibiotic-associated pseudomembranous colitis: An epidemiologic investigation of a cluster of cases. J. Infect. Dis. 1982; 145: 269-74.
14. Mogg G, Keighley M, Busdon D et al. Antibiotic associated colitis: A review of 66 cases. Br. J. Surg. 1979; 66: 38-42.
15. Wold A, Mendelow H, Bartlett J. Non-antibiotic associated pseudomembranous colitis due to toxin-producing clostridia. Ann. Int. Med. 1980; 92: 798-9.
16. Rudensky B, Rosner S, Sonnenblick M et al. The prevalence and nosocomial acquisition of Clostridium difficile in elderly hospitalised patients. Postgrad. Med. J. 1993; 69: 45-7.
17. Jackson B, Anders C. Idiopathic pseudomembranous colitis successfully treated by surgical excision. Br. J. Surg. 1972; 59: 154.
18. Price A, Davis D. Pseudomembranous colitis. J. Clin. Path. 1977; 30: 1.
19. Keighley M. Pseudomembranous colitis. In: Fazio V (ed.). Current Therapy in Colon and Rectal Surgery. Toronto: BC Decker Inc, 1990; 209-17.
20. Cozart J, Kalangi S, Clench M et al. Clostridium difficile diarrhoea in patients with AIDs versus non-AIDs controls: Methods of treatment and clinical response to treatment. J. Clin. Gastroenterol. 1993; 16: 192-4.
21. Kamthan A, Bruckner H, Hirschman S, Agus S. Clostridium difficile diarrhoea induced by cancer chemotherapy. Arch. Int. Med. 1992; 152: 1715-17.
22. Lamont J, Trnka Y. The therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet 1980; 1: 381.
23. Bolton R, Sherriff R, Read A. Clostridium difficile associated diarrhoea: A role in inflammatory bowel disease? Lancet 1980; 1: 383.
24. Lishmann A, Al-Jumaili I, Record C. Spectrum of antibiotic associated diarrhoea. Gut 1981; 22: 34-7.
25. Smith H. Microbial surfaces in relation to pathogenicity. Bacteriol Rev. 1977; 41: 475-500.
26. Fekety R, Shah A. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993; 269: 71-5.
27. Bartlett J. Clostridium difficile: Clinical considerations. Rev. Infect. Dis. 1990; 12: 243-51.